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BIOTRANSFORMASI CIS/TRANS 3,7-DIMETIL-2,6-OKTADIEN-1-OL 
OLEH SACCHAROMYCES CEREVISIAE 
 
ABSTRAK 
Biotransformasi geraniol and nerol menggunakan Saccharomyces cerevisiae telah 
dijalankan. Linalool dan geraniol dihasilkan sebagai produk utama dengan 
menggunakan sistem sel tumbuh, tetapi hanya pengisomeran nerol kepada geraniol 
berlaku apabila sel rehat digunakan. Reduktif biotransformasi geraniol adalah lebih 
berkesan menggunakan sistem sel rehat. Kombinasi rekabentuk factoran penuh 
dengan kaedah respons permukaan (RSM) digunakan untuk menilai kesan 
ketumpatan sel, kepekatan substrat dan masa biotransformasi atas penghasilan 
produk. Produktiviti meningkat seimbang dengan ketumpatan sel. Namun, 
kerencatan sel tumbuh diperhatikan apabila substrat dalam kepekatan tinggi 
digunakan. Keadaan yang optimum untuk biotransformasi geraniol adalah 1.36 g/L 
kepekatan substrat dan 60 g/L ketumpatan sel dalam masa 38 jam, dengan 
penghasilan 2.21 g/L citronellol dan 1.03 g/L nerol. Kepekatan optimum untuk 
linalool dan α-terpineol ialah 0.568 g/L dan 0.209 g/L masing-masing, dan dicapai 
dengan menggunakan 1.98 g/L kepekatan substrat nerol dan 35.8 g/L ketumpatan sel 
dalam masa 8.5 hari. Dengan anggapan penglibatan dua tapak aktif (ES yang 
produktif dan SE yang tidak produktif), kajian kinetik menunjukkan bahawa 
kerencatan kompetitif terlibat dalam proses biotransformasi tersebut. Nilai pemalar 
Michaelis-Menten, Km, dan kadar maksimum biotransformasi, vmax, diperolehi. Ki 
ialah pemalar pemisahan untuk kompleks SE yang tidak produktif. Kenaikan 
kepekatan substrat menyebabkan kenaikan pembahagian kompleks SE dan SES 
(ternar) dalam enzim, justeru mengakibatkan kerencatan walaupun tapak kerencatan 
mempunyai tarikan yang lemah untuk substrat (Ki >Km). 
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BIOTRANSFORMATION OF CIS/TRANS 3,7-DIMETHYL-2,6-OCTADIEN-
1-OL MEDIATED BY SACCHAROMYCES CEREVISIAE 
 
ABSTRACT 
 
Biotransformation of geraniol and nerol mediated by Saccharomyces cerevisiae was 
performed. Linalool and geraniol were mainly obtained from nerol using growing 
cells but only isomerisation to geraniol occurred using resting cells. Reductive 
biotransfomation of geraniol to citronellol was apparently more effective with resting 
cells system. Combination of full factorial design with response surface methodology 
(RSM) was applied in order to evaluate the effects of cell density, substrate 
concentration and biotransformation time on product concentrations. The 
productivity increased proportionally with cell density. However, inhibition was 
observed at higher substrate concentrations. The optimum conditions for 
biotransformation of geraniol were found to be 1.36 g/L substrate concentration and 
60 g/L cell density at 38 h, with 2.21 g/L citronellol and 1.03 g/L nerol formed. 
Linalool and α-terpineol achieved their optimums at concentrations of 0.568 g/L and 
0.209 g/L respectively, using 1.98 g/L of substrate nerol and cell density of 35.8 g/L 
after 8.5 days. Kinetic studies assumed a two-site model (productive ES and non-
productive SE) and revealed that a non-competitive substrate inhibition was involved 
in the biotransformation processes. The corresponding values of Michaelis-Menten 
constant, Km, and maximum biotransformation rate, vmax were obtained. Ki represents 
the dissociation constant for non-productive SE complex. Increase in substrate 
concentration leads to the increase in the proportion of SE and SES (ternary) 
complexes in the enzyme, causing inhibition even though the inhibitory sites has 
poor affinity for the substrate (Ki >Km). 
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CHAPTER 1 
INTRODUCTION 
 
1.1 Flavors and Fragrances 
 
The ever-growing market and potentiality in food and beverages industries 
have triggered the development and a strong demand for flavors and fragrances. 
Successful production of new items with assured quality, commercialization and 
enhancement on the characteristics of current products has always been a target for 
these companies when facing a tough market competition in the world of food and 
beverages. In order to fulfill the market of more energetic demands from exigent 
consumers, flavor can be among the most valuable ingredient as it plays a crucial 
role in determining the satisfactoriness for a specified food product and influences 
consumers’ further consumption of food.  
Flavors can be defined as a complex combination of attributes such as taste, 
aroma, texture and pungency (Bomben et al., 1973). Volatile organic compounds 
(VOC) of food and beverages, generally called aroma compounds, are divided into 
classes such as aldehydes, alcohols, ketones, esters, lactones, ethers and terpenes. 
They are present at very low concentrations, typically at mg/L or g/L levels in natural 
sources (Ribeiro Jr. et al., 2004) and are the main contributor to the flavors. Analysis 
on different kinds of fruits indicates more than 6000 compounds are constituents of 
their aroma (Bai et al., 2007) and every single aroma compound has different 
contributions on the final aroma of a fruit due to their dissimilar molecular 
characteristics and concentrations (Raisi et al., 2008). In addition, purification of 
natural materials, especially essential oils, led to the identification of aroma-active 
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materials such as benzaldehyde, cinnamaldehyde and vanillin (Rowe, 2005). The 
increased knowledge of organic chemistry has made a revolution to the flavor and 
fragrance industry, when these aroma compounds could now be synthetically and 
biologically produced.  
 
1.2 Biotechnological Route 
 
More than one hundred years ago, biotechnology was employed to do 
chemical transformations on non-natural man-made organic compounds. At present, 
the application of biotechnological route encompasses several areas of interests, 
especially pharmaceutical, food, beverage and fuel, which leads to development of 
new products with improved economics. A substantial increase has been observed in 
the application of biocatalysis and biotransformation to produce fine chemicals.  
Numerous bacteria, yeasts and fungi are used to catalyze chemical reactions 
from renewable feedstocks and ever since, have reaped in much attention owing to 
its higher reaction rate, higher product purity, less energy consumption and fewer 
negative impacts on the environment. Enhancement in molecular biology and genetic 
engineering have also steered the improvement and understanding of biochemical 
pathways which make possible the production of flavor molecules in a natural way. 
Microbial cells and their components are used in bioconversions and de novo 
syntheses in order to produce individual flavor compounds such as alcohols, 
aldehydes, ketones, acids, esters, aromatic compounds, terpenes, lactones, pyrazines 
etc. This knowledge is now applied to designing commercially viable processes, 
including scale-up, process optimization, and improved product recovery (Labuda, 
2009). 
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Biocatalysis and biotransformation have always been active participants in 
the field of biotechnology and the fact that the number of available enzymes 
exploitable in performing selective biotransformation into a myriad of desired 
products continues to expand, bioconversion processes are advancing at an 
increasing rate. The utilization of biocatalysts in bioprocesses has continued to 
emerge and constantly being recognized as attractive alternatives for the synthesis of 
various important and commercially useful compounds as auxiliaries to the 
traditional chemical approaches over the past years. Consequently, infiltration of 
biotechnological production processes to the chemical industry will extend into 
agriculture and pharmaceuticals sectors. Production of chemicals using engineered 
microorganisms and enzymes could generate global revenue of $1.8 trillion (USD), 
with one-ﬁfth of the chemical industry is expected to be dependent on synthetic 
biology by 2015 (Singh, 2011). 
 
1.3 Problem Statement 
 
Aroma compounds are key impact substances in the food and fragrance 
industries. The increased customer demand for natural flavors and fragrances has led 
to intensified attempts to increase the rate of production of these enantiomerically 
pure substances; both the percentage yield as well as its enantiomeric excesses (e.e.). 
The use of flavors in particular, does not only target the food and cosmetic industries. 
Its application has also been introduced in the cancer treatment scheme (Carnesecchi 
et al., 2001). It is well-known that the consumption of fruits and vegetables could 
reduce and at the same time prevent the occurrence of cancer (Steinmetz et al., 1994), 
and this has therefore triggered a new scope of research where the formation of 
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active compounds mainly found in fruits such as terpenes and terpenoids are 
mimicked based on their natural existence.  
The major sources of natural flavorings in general are plants and some of 
these are also chemically synthesized. However, the preference of consumers 
towards products defined as “natural” has triggered the increasing demand for flavors 
isolated from natural sources, in which the starting materials are natural (plants and 
animal sources). Nevertheless, several shortcomings of the production are stalwartly 
elucidated through the large fluctuations of quality, price and supply of the natural 
flavors extracted from plants, attributed to the variability in the composition and 
yield of the final products from different geographical sources, in addition to the 
dependence of sources on the weather, risk of plant diseases and seasonal variation in 
supply etc (Berger et al., 2000).  
Recent developments on biotechnology have enabled the production of 
natural flavorings to be carried out economically and more efficiently. Microbial 
whole cells have shown great potential for biotransformation owing the ease with 
which the microorganisms can be cultivated and used in the bioreactors (Kashi et al., 
2008). However, existing successful chemical processes and several biocatalyst-
associated problems, such as lack of stability and limited operating range, have often 
thwarted efforts to substitute them with biotransformation processes. Most of the 
aroma compounds are secondary metabolites that cells do not require for growth. 
They are present at low concentrations during the logarithmic growth phase, but 
appear in large quantities during the stationary phase. Very often, flavor compounds 
partition to lipid structures due to their hydrophobicity, targeting cellular membranes 
for product accumulation during microbial processes. In other words, these 
compounds and/or their precursors inflict cytotoxicity effects on the cells (Schrader, 
5 
 
2007). Inhibitory effects often cause impediments for higher yield production, 
resulting in high costs for downstream processing comprising isolation and 
purification steps. 
The aim of this research is to study the potentiality of Saccharomyces 
cerevisiae to mediate the biotransformation of monoterpenoids geraniol and nerol, 
respectively. S. cerevisiae or baker’s yeast is a species of budding yeast. It is perhaps 
the most useful yeast owing to its use since ancient times in baking and brewing. 
Besides being widely used in the fermentation and brewing industries, S. cerevisiae 
has found its application in the production of useful chemical compounds (Attfield, 
1997) and has been proven effective with relatively high e.e. (Ward and Young, 
1990).  
While bioconversion of terpenes has been extensively explored using both 
prokaryotic and eukaryotic microorganisms (de Carvalho and da Fonseca, 2006), less 
interest has been allocated for the biotransformation of acyclic monoterpenes (e.g., 
geraniol and nerol) utilizing baker’s yeast. Then again, for many instances, the 
performance of S. cerevisiae is often outshone by other organisms. The presence of 
different enzymes causing overlapping activities of the cells plus many of the 
reductases involved have yet to be fully characterized also contributed to the little 
attention given.  
Nevertheless, with its distinct characteristics such as process robustness, 
ability to grow anaerobically, high tolerance to low pH, high sugar/ethanol 
concentrations that lower the risk of contamination (Nevoigt, 2008), and involvement 
in well-established large-scale fermentation, baker’s yeast offers significant 
advantages as a versatile biocatalyst. Other attractiveness includes being inexpensive, 
readily available and non-pathogenic which earns its status to be categorized as 
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GRAS (Generally Regarded As Safe) organism (Ostergaard et al., 2000). Besides, 
the capability of S. cerevisiae in carbon–carbon double bonds reductive 
biotransformation has been well defined and made it possible to perform 
biotransformation of terpenes and their derivatives. 
 
1.4 Objectives 
 
The objectives set in for this particular research can be classified into three key 
areas, as listed below:  
1. To study the biotransformation of cis and trans 3,7-dimethyl-2,6-octadiene-1-
ol (geraniol and nerol) respectively, using baker’s yeast type-II 
(Saccharomyces cerevisiae). 
2. To investigate the effect of substrate concentration, cell density, glucose 
concentration and time towards the biotransformation processes.   
3. To optimize the biotransformation processes by using Response Surface 
Methodology (RSM) and to propose a kinetic model that describe the 
biotransfomation processes. 
 
1.5  Scope of Research 
 
In this research, biotransformation experiments were conducted in batch 
mode with monoterpenoids geraniol and nerol as the main precursors. The capability 
of microorganisms in converting these substrates into more valuable aroma 
compounds offers a remarkable alternative source of natural flavors (Demyttenaere, 
2001). Baker’s yeast type-II in its dried form was used as the biocatalyst throughout 
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the work. Evaluation of the sustainability and stability of the baker’s yeast towards 
inhibitory effects was carried out based on cell density, substrate/product 
concentration and biotransformation time. Identification and concentration of 
products were later verified using gas chromatography techniques. Subsequently, 
optimum values for the parameters involved in the biotransformation processes were 
determined using statistical approach. Lastly, a suitable model was developed for 
kinetic inhibitory studies. 
 
1.6 Organization of Thesis 
 
This thesis contains five chapters encompasses Introduction, Literature 
review, Materials and methods, Result and discussions, Conclusion and 
recommendations for future research. Chapter 1 introduces the background and 
importance of flavors and fragrances and their production via biotechnological route, 
followed by objectives of this study. Chapter 2 highlights the review on literatures 
relevant to this study, which includes several successful works on biotransformation 
of terpenoids and the significant usages of baker’s yeast (Saccharomyces cerevisiae) 
in this particular area of interest. The materials and experimental procedures required 
in this study is placed under Chapter 3, while Chapter 4 presents and discusses the 
experimental results and optimization via statistical approach, wrapped up with the 
development of model for kinetic studies. Last chapter draws the conclusion for this 
research work accompanied with several recommendations for future studies.  
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1 Terpenes  
 
According to Encyclopedia Britannica, terpenes are any of a class of 
hydrocarbons occurring widely in higher plants and animals, and empirically 
constructed from isoprene. These natural organic substances are ubiquitous in all 
classes of living things and constitute the largest and most widespread family of 
natural products. To date, over 55,000 terpenes have been isolated, doubling the 
amount each decade (Breitmaier, 2006). Terpenes exist in the form of hydrocarbons, 
alcohols, ethers, aldehydes, ketones, carboxylic acids, esters. They play an important 
role as the major biosynthetic building blocks within nearly every living organism.  
Terpenoids, also known as isoprenoids, belong to a subclass of the 
prenyllipids (terpenes, prenylquinones, and sterols) and represent the oldest group of 
small molecular products synthesized by plants (Leray, 2009). Terpenoids are 
relatively inexpensive, readily available and renewable natural precursors 
(Demyttenaere and De Kimpe, 2001). These compounds comprise one, or more, 
basic isoprene units, assembled and modified in thousands of ways. In other words, 
terpenoids are the resulting compounds after modifications on terpenes, such as by 
rearrangement of the carbon skeleton wherein methyl groups are moved or removed 
and also oxidation (addition of oxygen atoms). Most of them are multi-cyclic 
structures that differ from one another not only in functional groups but also in their 
basic carbon skeletons.  
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Just like terpenes, classification of the terpenoids can be established 
according to the number of isoprene units incorporated in the basic molecular 
skeleton used, as shown in Table 2.1. The basic molecular formulas of terpenes are 
multiples of that, (C5H8)n where n is the number of linked isoprene units. The 
isoprene units attach to one another by linking the head of one unit to the tail of 
another to form linear chains or they are arranged to form rings. These observations 
are known as the isoprene rule or the C5 rule. 
 
Table 2.1: Classification of terpenoids (Leray, 2009) 
Terpenoids Number of Isoprene Units Number of Carbon Atoms 
Hemiterpenoids 1 5 
Monoterpenoids 2 10 
Sesquiterpenoids 3 15 
Diterpenoids 4 20 
Sesterterpenoids 5 25 
Triterpenoids 6 30 
Tetraterpenoids 8 40 
Polyterpenoids Large number of isoprene units 5n (n>8) 
 
Terpenes and terpenoids are generally associated with characteristic 
fragrances as they impart a wide variety of pleasant and floral scents and are used 
extensively for their aromatic qualities. In particular, monoterpenes and 
sesquiterpenes are the primary constituents of essential oils from many types of 
plants, while the other terpenes are constituents of balsams, resins, waxes, and rubber 
(Leray, 2009). Generally, all terpenoids are synthesized through the condensation 
of C5 isomeric precursors dimethylallyl pyrophosphate (DMAPP) and isopentenyl 
pyrophosphate (IPP), which can be derived either from mevalonate (MVA) or non-
mevalonate (MEP) pathways from pyruvate of higher plants, as shown in Figure 2.1.  
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Figure 2.1: Biosynthetic pathways of terpenes (Carrau et al., 2005) 
 
 
The important products generated by the action of enzymes known as 
prenyltransfereases include geranyl, farnesyl, geranylgeranyl pyrophosphates, 
squalene and phytoene, leading to the diverse formation of terpenoids (Humphrey 
and Beale, 2006). While geranyl pyrophosphate (GPP) plays the role as a precursor 
for monoterpenes as well as of a number of secondary plant metabolites, farnesyl 
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pyrophosphate (FPP), the product of FPP synthase, is the precursor to a wide variety 
of sesquiterpenes.  
The mevalonic acid pathway (MVA) takes place in the cytosol. Organisms 
including higher eukaryotes and many bacteria produce terpenoids through MVA or 
HMG-CoA reductase pathway, the pathway that also produces cholesterol. 
Isopentenyl pyrophosphate (IPP) is formed from acetyl-CoA via mevalonic acid, 
which is then be isomerized to DMAPP by IPP isomerase. The mevalonic acid 
independent pathway is an alternative metabolic pathway discovered in the late 
1980s that leads to the formation of IPP and DMAPP. Initially, pyruvate and 
glyceraldehyde 3-phosphate are condensed to 1-deoxy-D-xylulose 5-phosphate (DXP) 
by DOXP synthase. In the second step, DXP is rearranged and reduced by DOXP 
reductase yielding 2-C-methyl-D-erythritol 4-phosphate (MEP). MEP is 
subsequently converted into 4-diphosphocytidyl-2-C-methylerythritol, and a multiple 
steps ensuing will form IPP and DMAPP.  
In an investigation work of mono- and sesquiterpene biosynthesis by baker’s 
yeast (Carrau et al., 2005), monoterpenes α-terpineol and linalool were found to be 
the main products afforded by all the S. cerevisiae wine yeasts tested. Judging by the 
effect of nitrogen and redox conditions (microaerobic and anaerobic) on the terpenes 
production, it was suggested that leucine catabolism pathway (MCC pathway), 
known to occur in mitochondrion in eukaryotic cells, could have been accounted for 
the formation of the monoterpenoids, while the sesquiterpenoids followed the 
cytosolic sterol metabolic pathway already described in yeast (Carrau et al., 2005). In 
another work, both wild-type and farnesyl diphosphate synthase (FPPS)-defective S. 
cerevisiae mutant strains were also discovered in having the ability to produce 
monoterpene-derived compounds (Oswald et al., 2007). 
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2.1.1 Monoterpenoids 
 
Monoterpenes hydrocarbons dominate in most essential hydrocarbons. They 
are the most representative molecules constituting 90% of the essential oils and allow 
a great variety of structures. Monoterpenes consist of two isoprene units that belong 
to the C10 representatives of the terpenoid family of natural products, and found their 
usefulness in the perfumery and flavor industries. Monoterpenoids (monoterpene 
oxygen-containing derivatives) diverge from higher isoprenoid biosynthesis at the 
level of GPP. The vast majority of the several hundred naturally occurring 
monoterpenes are cyclic, and they represent a relatively small number of skeletal 
themes multiplied by a very large range of simple derivatives, positional isomers and 
stereochemical variants (Croteau, 1987).   
It is well-known that geraniol and nerol are both geometric isomers (trans 
and cis isomers of 3,7-dimethyl-2,6-octadiene-1-ol, respectively) and belong to the 
most fundamental acyclic monoterpenoid alcohols. Their esters and aldehydes are 
also common. Figure 2.2 shows the chemical structures for both geraniol and nerol. 
Besides their use in food and flavor industry, these alcohols are also used for the 
synthesis of vitamins A and E (Mercier and Chabardes, 1994).  
OH
geraniol
OH
nerol                          
 
Figure 2.2: Chemical structures of geraniol and nerol (Surburg and Panten, 
2006) 
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Geraniol 
Geraniol is found widely as a chief constituent in essential oils including 
ilang-ilang oil, palmarosa oil, geranium oil, orange flower oil, lemongrass oil, hops 
oil, and lavender oil. A common usage of geraniol is found in perfumery and 
flavoring industries, where it is used for flavors such as peach, raspberry, red apple, 
orange, lemon etc. Geraniol is also a natural antioxidant. It has been shown that 
geraniol inhibited the proliferation of MCF-7 human breast cancer cells and rodent 
mammary tumor development (Duncan et al., 2004). On top of that, geraniol 
suppressed the growth and polyamine biosynthesis in human colon cancer in which it 
caused a 70% inhibition of cell growth and a 50% decrease of ornithine 
decarboxylase activity, a key enzyme of polyamine biosynthesis, which is enhanced 
in cancer growth (Carnesecchi et al., 2001). Burke and co-workers in their studies 
about the effects of isoprenoids on cancer of the pancreas reported that farnesol, 
geraniol, and perillyl alcohol suppressed pancreatic tumor growth without 
significantly affecting blood cholesterol levels (Burke et al., 1997). 
 
Nerol 
Nerol occurs in small quantities in many essential oils such as lemongrass, 
where it is always accompanied by geraniol. Nerol was originally isolated from 
neroli oil, and was later discovered in the oils of petitgrain, rose, Mexican lignaloes 
and Helichrysum angustifolium. Nerol possesses an agreeable, rose-like odor and 
reveals close similarity with geraniol in terms of its chemical behavior. Nerol 
undergoes the same reactions as geraniol, but cyclizes more readily in the presence 
of acids as illustrated in Figure 2.3 and is commonly used in perfumery and for 
bouquetting citrus flavors (Surburg and Panten, 2006). 
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Figure 2.3: Cyclization of nerol in the presence of acid (Fogiel, 1978) 
 
Citronellol 
Citronellol occurs as a mixture of its two enantiomers; the pure (+) or (–) 
form is seldom found. Citronellol in the (–)-form is common in geranium and rose 
oils, both of which may contain up to 50% citronellols (Surburg and Panten, 2006) 
and has a finer rose odor than the (+)-enantiomer with a sweet, peach-like flavor. The 
United States FDA considers both substances GRAS (Generally Recognized as Safe 
for food use) (Weatherston, 2005). Figure 2.4 shows the chemical structures for both 
enantiomers of citronellol.               
    
OH OH
R-enantiomer S-enantiomer
 
 
Figure 2.4: Chemical structures of R,S-citronellol (Surburg and Panten, 2006) 
15 
 
Citronellol undergoes the typical reactions of primary alcohols. Compared 
with geraniol, which contains one extra double bond, citronellol is relatively stable 
and can be converted to citronellal by dehydrogenation or oxidation (Surburg and 
Panten, 2006). Besides, citronellol has a long history as one of the most widely used 
fragrance materials in cosmetics, flavorings and fragrances particularly for rose notes 
and for floral compositions in general. As a flavor material, citronellol is added for 
bouquetting purposes to citrus compositions (Surburg and Panten, 2006). Citronellol 
also acts as a pesticide active ingredient that is used on food crops and ornamentals 
to attract mites, a major agricultural pest. Citronellol is usually used in tiny amounts 
and shows minimal to no toxicity in laboratory studies, hence, no harm is expected to 
humans or the environment if label instructions are followed (Weatherston, 2005). 
 
Linalool 
Linalool is a colorless liquid that can be found mainly in rosewood, freesia, 
lavender, coriander, basil, citrus leaves and linaloe. It is an allylic isomer of geraniol 
and nerol (Sell, 2003). Linalool occurs as one of its enantiomers in many essential 
oils. For example, (+)-linalool is a chief constituent of coriander. On the other hand, 
(–)-linalool can be found in Ho oils from Cinnamomum camphora (Surburg and 
Panten, 2006). Figure 2.5 illustrates the chemical structures of (±)-linalool. 
 
R-enantiomer
OH
S-enantiomer
HO
 
 
Figure 2.5: Chemical structures of R,S-linalool (Surburg and Panten, 2006) 
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Due to its fresh, floral odor, linalool is considered an important fragrance 
material for manufacturing scented products and cleaning agents. Besides, it has been 
shown that linalool and its corresponding acetate play a major role as potentially 
anti-inflammatory agents (Peana et al., 2002). Tests performed also shown that 
linalool provide pharmacological effects of antinociceptive/antihyperalgesic 
(reduction of pain sensitivity) (Peana and Moretti, 2009). Linalool possesses 
antioxidant properties which is vital for the prevention of lipid peroxidation. It can 
also be used in therapeutic approaches to limit the damage caused by oxidation of 
unsaturated fatty acids (Peana and Moretti, 2009). Linalool can also be treated as 
insecticidal compound, showing effectiveness against fleas, mites, houseflies etc. and 
hence useful for household pest control, fumigation of food handling and storage 
facilities (Olkowski et al., 1995). 
 
α-Terpineol 
Terpineol or α-terpineol, is one of the most prevalent monocyclic 
monoterpenoid alcohols in nature. (R)-(+)-α-terpineol has a floral, typically lilac odor, 
while (S)-(−)-α-terpineol that occurs in conifer and lavandin oils, carries a pine smell 
characteristic (Sell, 2003). Although α-terpineol is found in many essential oils, only 
small quantities are commercially produced. Its typical commercial application 
includes in the production of soaps, cosmetics and flavors which is mainly used as 
various flavor compositions such as berry, lemon, lime, nutmeg, orange, ginger etc 
(Tan and Day, 1998). On top of that, α-terpineol displayed antimicrobial activity 
against Trichophyton mentagrophytes (Park et al., 2009), Staphylococcus aureus and 
Pseudomonas aeruginosa (Jirovetz et al., 2005). The structures of both enantiomers 
are illustrated in Figure 2.6. 
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Figure 2.6: Chemical structures of R,S-α-terpineol (Surburg and Panten, 2006) 
 
It is well-known that herbs and spices exhibit antimicrobial activity and the 
principle behind it is often attributed to the essential oil present in these spices. Many 
studies have been carried out and found that citronellol, geraniol and nerol shows 
antimicrobial properties (Arldoğan et al., 2002; Shin, 2003; Duarte et al., 2007). 
These substances may be useful in clinical situations, where infectious diseases 
caused by a large variety of pathogenic bacteria in humans can be controlled and 
treated. In addition to that, these monoterpenoids are found to be one of the active 
ingredients that produce effective natural plant-based insect repellents (Taylor and 
Schreck, 1985; Barnard and Xue, 2004; Gillij et al., 2008), which find their 
potentialities to prevent and control the outbreak of insect-borne diseases. 
 
2.1.2 Production of Terpenoids 
 
Traditionally, terpenoids can be acquired via physical separation from plant 
or animal sources, which include essential oils, extracts and distillates or from animal 
sources. These extraction methods are usually vacuum- or steam- distillation, 
expression, concentration and extraction with organic solvents (Berger et al., 2000; 
Margetts, 2005).   
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Nevertheless, active components within these sources are often present in 
small quantities or in bound form or are only found in exotic plants, making isolation 
difficult and the flavor products expensive (Janssens et al., 1992). Also, the 
stumbling blocks such as heat, chemical solvents, and problems associated with 
product contamination and degradation (Raisi et al., 2008) found in these techniques 
have rendered them less effective when aromatic compounds obtained from the raw 
materials tend to be distorted from the original character of the odor.  In addition, 
large-scale productions are often inhibited by seasonal variation, and variability in 
the composition and the yield of the final product is rather difficult to control. 
Consequently, the quality and price of the given essential oil frequently fluctuates 
over the year (Berger et al., 2000).  
Currently, advances in chemical processes have enabled these flavour 
compounds to be produced synthetically in satisfactory yields and high production 
rates. However, one of the drawbacks of chemical processes is the formation of 
undesirable racemic mixtures that could only be avoided through the use of chiral 
building blocks suitable for the total synthesis of the target molecule. However, these 
building blocks could hardly be obtained from readily available compounds or 
natural products (Watanabe et al., 2005). In contrast, biotechnological production 
provides a feasible alternative for the production of flavour compounds. The US and 
European legislations have acknowledged that enzymatic or microbial processes as 
capable of producing enantiospecific compounds labelled as ‘natural’, which has 
been advantageous for the production of terpenoids (Demyttenaere, 2001). 
Biotechnological production of terpenoids can be either via de novo syntheses 
(fermentation) using simple substrates like sugar and alcohol or through 
biotransformation of precursor compounds to flavour end-products.  
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2.2 Biotransformation 
 
Biotransformation is a chemical modification process on an organic 
compound using microorganisms as biocatalyst. Usually the catalyst is an enzyme, or 
whole-cell microorganism containing an enzyme or several enzymes. Conversion 
from one material into another using whole living organisms is usually called 
“bioconversion” (Pandey et al., 2007). Biotransformation produced a wide range of 
products as advances in this technology have led to the increase in development of 
scientifically novel and commercially successful processes to manufacture specialty 
chemicals, especially flavors and fragrances. These processes often use novel 
enzyme systems and have acquired multidisciplinary research in their development 
(Cheetham, 1993).  
Figure 2.7 shows the rapid increase on the total number of biotransformation 
processes that have been started on an industrial scale over the past years. Currently, 
biotransformation products are being produced at a scale from below 100 up to 
10000 tons per annum and the number of biotransformation used at the industrial 
scale is doubling every decade, indicating the enormous biotechnological potential of 
the use of cells/enzymes as biocatalysts (Rehm, 2008).  
 
Figure 2.7: Cumulative number of biotransformation processes on an industrial 
scale (Straathof et al., 2002) 
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Generally, the flavor products obtained by microbial routes are optically pure, 
extra-cellular, and suitable for commercial exploitation because of easy downstream 
processing and high yields (Agrawal, 2004). Some of the high-value 
biotransformation products are chiral compounds serving as intermediates or 
precursors for the synthesis of pharmaceuticals. For example, many enzymes isolated 
from pseudomonads as well as some whole Pseudomonas cells are currently used as 
biocatalysts in industrial biotransformations (Rehm, 2008)  
 
2.2.1 Biocatalysts versus Chemocatalysts 
 
Biocatalysts refer to enzymes, cell organelles or whole-cells, in which the 
latter can be growing or non-growing, and viable or non-viable. They can be free or 
immobilized and of microbial, plant or animal origin. Microbial cells are genetically 
engineered both for the purpose of increasing the enzyme production and for use as 
biocatalysts (Averill et al., 1991). Due to high metabolic rates which promote the 
rapid microbial growth of microorganisms, attributed to their high surface to volume 
ratio, microbial cells are often considered as preferred choice for biotransformation, 
which in turn translates to a far more efficient and economical process. Furthermore, 
microbial cells are easier to grow in culture and possess effective cell wall structure 
that gives its high mechanical strength (Roberts et al., 1995). 
The most important requirements for a catalyst in technical processes are 
selectivity, activity and stability. Most of chiral natural flavors occur in 
enantiomerically enriched form. Because different enantiomers or regioisomers 
provide different sensorial properties, their specific synthesis is much useful and 
favorable (Brenna et al., 2003). Biocatalysts are often significantly superior to 
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classical chemocatalysts due to their capability of catalyzing a large number of 
stereo- and regioselective chemical manipulations (Serra et al., 2005). The use of 
enzymes and several wild-type microorganisms in particular can prevent undesirable 
secondary reactions and side products (Carballeira et al., 2009a). Another important 
advantage of biocatalysts is that they can reduce or eliminate the use or generation of 
hazardous substances (Carballeira et al., 2009a) and are completely biodegradable 
(Serra et al., 2005), thus creating a more environmentally-friendly approach.  
However, there are still some major drawbacks on the acceptance of 
biocatalysis on the whole over the last 20 years (Bommarius and Riebel, 2004). 
Limited number and availability of enzymes plus long development times of new 
biocatalysts owing to an insufficient knowledge base of biocatalysis and 
biotechnology remained a problem and a challenge. Some of the advantages and 
disadvantages of biocatalysts over chemical catalysts are listed in Table 2.2.  
 
Table 2.2: Advantages and disadvantages of biocatalysts (Buchholz et al., 2005) 
Advantages Disadvantages 
 Low temperatures required 
 Active at moderate pH 
 Stereo- and regioselective 
 Low energy consumption 
 Less by-products 
 Non-toxic when correctly used 
 Can be reused (immobilized) 
 Can be degraded biologically 
 Unstable at high temperatures 
 Unstable at extreme pH values 
 Unstable in aggressive solvents 
 Inhibited by some metal ions 
 Hydrolyzed by peptidases 
 Some enzymes are still very 
costly 
 Require expensive co-substrates 
 
Despite the shortcomings of biocatalysts, recombinant DNA technology and 
development of molecular biology have led to the discovery of many novel enzymes 
of improved catalytic performances (Riva, 2001). Alongside with process 
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development towards higher stability and volumetric productivity, the strengthening 
of biocatalytic approach in synthetic routes has eventually become more significant 
and dramatically advanced in recent years (Bommarius and Riebel, 2004).  
Many literatures have reported the successful use of biocatalysts in several 
chemical processes (Zaks, 2001; Thomas et al., 2002) and a prominent example can 
be observed in the production of vitamin C. Vitamin C or L-ascorbic acid (L-AA) is 
an indispensable nutrient for human to carry out several physiological functions 
(Bremus et al., 2006). For the past 70 years, L-AA is being produced via Reichstein 
process, which involves a series of chemically based unit operations and a single 
biocatalytic step. However, there has been increasing pressures to develop a 
sustainable alternative process as the catalyst used involves environmentally 
hazardous chemicals (Hancock and Viola, 2002). Besides, process efficiency and 
economic factor give rise to huge interest to find other substitutes as this process is 
still the most energy consuming (Bremus et al., 2006). As a result, microbiological 
biotransformations using reasonable raw materials have been given due attention.  
Several strategies have been followed in shifting the present L-AA synthesis 
methods from chemical to biocatalytic routes, by using different bacterial strains 
(Hancock and Viola, 2002). However, most of the known approaches do not involve 
direct L-AA synthesis, instead produce 2-keto-L-gulonic acid (2-KLGA) as a key 
intermediate that can be converted to L-AA via conventional chemical processing 
technology (Bremus et al., 2006). Therefore, the strategy for the improvement of 2-
KLGA production is to generate recombinant strains using genetic engineering 
methods. Figure 2.8 shows the comparison of the L-ascorbic acid synthetic processes. 
The traditional Reichstein Process takes in all five chemical steps with one 
biocatalytic step, produced an overall yield of only 55% (Bommarius and Riebel, 
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2004), while the one-step fermentation (glucose fermentation) and two-step 
fermentation (sorbitol fermentation) processes to 2-KGLA by way of subsequent 
chemical steps into L-AA, provide better alternatives with fewer processing steps. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.8: Comparison of processes for the synthesis of L-ascorbic acid 
(Bommarius and Riebel, 2004) 
 
 
2.2.2 Whole-Cell versus Isolated Enzymes 
 
Generally, biocatalysts can be divided into two main subgroups: whole-cells 
or their isolated enzymes. Currently, at least 134 biotransformation processes are 
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operating industrially with a mix of whole-cell and isolated enzyme catalysts 
(Straathof et al., 2002), and according to a poll conducted, 22 out of 38 large scale 
asymmetric syntheses involved enzymatic or whole-cell biotransformations 
(Yazbeck et al., 2004). 
Enzyme-catalyzed reactions have been widely used in laboratory or industrial 
scale, whereas, whole-cell catalyzed reactions have been commonly restricted to 
special cases (Carballeira et al., 2009b). In choosing the best biotransformation 
system, factors to be taken into consideration in deciding whether an enzyme or 
whole-cells should be used include the availability, the number of steps involved, 
yield, cofactor requirement, byproduct formation, the required product purity, price, 
etc (Averill et al., 1991). Whole-cell biocatalysts can offer several advantages over 
the use of isolated enzymes in biocatalysis. They are a convenient and stable source 
of enzymes that are often synthesized by cells in response to the presence to the 
substrate (D'Arrigo et al., 2000). S. cerevisiae and Penicillium sp. are some of the 
inexpensive whole-cells that are usually available from fermentation processes. 
Whole-cell can be obtained in alternative forms of growing cultures, resting 
cultures, spore cultures or immobilized cultures (Roberts et al., 1995). Growing cell 
cultures represent the simplest biotransformation procedures whereby in a batch-
grown culture, substrate will be added to the medium, followed by incubation that 
will be carried out until all of the added substrate disappears and/or the 
bioconversion ceases. At fixed intervals, a fresh sample of the growth medium will 
be drawn out to monitor the extent of substrate disappearance and product formation. 
Resting cells are non-growing live cells obtained by removing growing cells at a time 
in the growth phase when the potential of the cells to take on the desired 
biotransformation is optimal. The cells are then resuspended in a weak compatible 
